Distinct baseline immune profiles can predict response and resistance to different types of CAR-T cells.
Case report: Primary laryngeal NK/T-cell lymphoma
Study findings presented at ASCO 2019
More efficient, safer therapy may be on horizon
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement